about
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Th...
Read More
1.71
-0.05
(-2.84%)
51,995
XNAS Volume
XNAS 23 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Exicure Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..